Adding bortezomib to R-CHOP didn’t improve survival in diffuse large B-cell lymphomaSeptember 29, 2017Aggressive Lymphomas
FDA grants accelerated approval to copanlisib for relapsed follicular lymphomaSeptember 20, 2017Aggressive Lymphomas
Biosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive Lymphomas
Solid organ transplantation contributes significantly to incidence of NHL among children and adolescentsAugust 3, 2017Aggressive Lymphomas
Copanlisib makes inroads against relapsed/refractory follicular lymphomaJuly 11, 2017Indolent Lymphoma
R-CHOP matched more intense regimens for overall survival in high-risk, untreated DLBCLJuly 10, 2017Aggressive Lymphomas
Pembrolizumab + rituximab boost response rates in relapsed follicular lymphomaJune 26, 2017Indolent Lymphoma
